Imperial College London
Mr Duncan Spalding

MrDuncanSpalding

Faculty of Medicine, Department of Surgery & Cancer

Clinical Senior Lecturer in Hepato-Biliary Surgery
 
 
 
//

Contact

 

+44 (0)20 3313 3941d.spalding

 
 
//

Location

 

Hammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Sarker:2018:10.1200/JCO.2018.36.15_suppl.2509,
author = {Sarker, D and Plummer, ER and Basu, B and Meyer, T and Huang, K-W and Evans, TRJ and Spalding, D and Ma, YT and Palmer, DH and Chee, CE and Habib, NA},
doi = {10.1200/JCO.2018.36.15_suppl.2509},
publisher = {AMER SOC CLINICAL ONCOLOGY},
title = {Preliminary results of a first-in-human, first-in-class phase I study of MTL-CEBPA, a small activating RNA (saRNA) targeting the transcription factor C/EBP-α in patients with advanced liver cancer.},
url = {http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.2509},
year = {2018}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Sarker,D
AU  - Plummer,ER
AU  - Basu,B
AU  - Meyer,T
AU  - Huang,K-W
AU  - Evans,TRJ
AU  - Spalding,D
AU  - Ma,YT
AU  - Palmer,DH
AU  - Chee,CE
AU  - Habib,NA
DO  - 10.1200/JCO.2018.36.15_suppl.2509
PB  - AMER SOC CLINICAL ONCOLOGY
PY  - 2018///
SN  - 0732-183X
TI  - Preliminary results of a first-in-human, first-in-class phase I study of MTL-CEBPA, a small activating RNA (saRNA) targeting the transcription factor C/EBP-α in patients with advanced liver cancer.
UR  - http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.2509
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000442916001289&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER  -
Download